-
A delayed consent approach to informed consent used by researchers in a recent study comparing outcomes in ST-elevation myocardial infarction patients (STEMI) resulted in ethical concerns being voiced.
-
Direct-to-consumer genetic testing presents multiple ethical concerns, including individuals being given misleading or inaccurate information. In July 2014, the U.S. Food and Drug Administration announced coming draft guidelines for the regulation of laboratory developed tests.
-
Technology allows for preclinical detection of some brain disorders or conditions, but such testing also presents numerous ethical concerns.
-
Critically ill patients known wishes not to be resuscitated or placed on life support were ignored 60% of the time, according to a 2014 study mainly because of efforts by patients families to countermand their known wishes, and inability to locate documentation of patients wishes.
-
Advance directives and proxy opinions are equally effective in influencing doctors decisions, but having both has the strongest effect, says a 2014 study.
-
A minority of nephrologists favor rewards for organ donation, many agree with some compensation, and a considerable majority favor donor health insurance, according to a recent survey.
-
Patient access employees are responsible for knowing the general policies and procedures of the hospital, emphasizes Angela Click, patient access services manager at OSF St Joseph Medical Center in Bloomington, IL.
-
Patients rely on patient access employees to inform them of out-of-pocket costs, but accurate estimates are challenging to give. This challenge is due to changes in what is done clinically, provider contracts, patient co-morbidities, and the complexity of coverage.
-
Patient access leaders should expect surveyors from The Joint Commission or the Centers for Medicare and Medicaid Services (CMS) to interact directly with front-line staff in registration areas.
-
How do you protect a patients privacy? Some patient access employees get a deer-in-the-headlights look when surveyors ask this simple question, says Michael Sciarabba, MPH, CHAM, director of patient access at University of California, San Francisco.
